Oral, inhaled corticosteroids impose multiple burdens on quality of life in asthma

The most burdensome adverse events that patients with asthma reported when using inhaled and oral corticosteroids did not always cause them to stop therapy, according to a study published in Annals of Allergy, Asthma & Immunology.
Social stigma and psychosocial burdens associated with the use of these medications may limit treatment adherence as well, Vickram Tejwani, MD, assistant professor of medicine at Cleveland Clinic Lerner College of Medicine/Case Western University School of Medicine, and Respiratory Institute of Cleveland Clinic, and colleagues wrote.
“Asthma quality of life

The most burdensome adverse events that patients with asthma reported when using inhaled and oral corticosteroids did not always cause them to stop therapy, according to a study published in Annals of Allergy, Asthma & Immunology.
Social stigma and psychosocial burdens associated with the use of these medications may limit treatment adherence as well, Vickram Tejwani, MD, assistant professor of medicine at Cleveland Clinic Lerner College of Medicine/Case Western University School of Medicine, and Respiratory Institute of Cleveland Clinic, and colleagues wrote.
“Asthma quality of life